Printer Friendly

Included among recent SEC filings for initial public offerings, Eyeonics Inc. (Aliso Viejo CA) registered up to $86.25 million worth of common stock via Piper Jaffray.

IPO Sector: Included among recent SEC filings for initial public offerings, Eyeonics Inc. (Aliso Viejo CA) registered up to $86.25 million worth of common stock via Piper Jaffray. With its premium intraocular lenses (marketed under the name Crystalens), Eyeonics is working toward enabling patients to have cataract surgery and be able to leave their bifocals at the hospital. The lenses surgically replace cataract-affected lenses and help correct presbyopia, a refractive condition that keeps aging eyes from focusing properly on objects near at hand. Eyeonics' current product--the Crystalens Five-O--is a third-generation version of the lens; it has a fourth-generation version in clinical development. A direct sales force markets the product to ophthalmologists and other eye-care professionals, mainly in the U.S.
COPYRIGHT 2007 MedContent Media, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:IPO Sector
Publication:MondayMorning
Date:Sep 3, 2007
Words:121
Previous Article:U.S. stocks rallied Friday, capping the first monthly gain since May, after President George W. Bush and Federal Reserve Chairman Ben Bernanke...
Next Article:Weekly key rates in percent.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters